FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1181411000001109: Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21688301000001113 Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
60123301000001111 Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 100 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

8 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Is pack of Betamethasone+salicylic acid 0.05/3% scalp application false Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has active ingredient Glucocorticoid hormone false Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has active ingredient Betamethasone dipropionate false Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has active ingredient Betamethasone false Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has active ingredient Keratolytic agent false Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has active ingredient Salicylic acid false Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has active ingredient Topical agent false Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has manufactured dose form Basic dose form with liquid state of matter false Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has VMP Betamethasone+salicylic acid 0.05/3% scalp application false Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has specific active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has specific active ingredient Betamethasone dipropionate true Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has dispensed dose form Basic dose form with liquid state of matter true Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has VMP Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application false Inferred relationship Existential restriction modifier
Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has VMP Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) 100 ml Is a True Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Inferred relationship Existential restriction modifier
Diprosalic scalp application (PI) (Waymade Ltd) 100 ml Is a True Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Inferred relationship Existential restriction modifier
Diprosalic scalp application (Dowelhurst Ltd) 100 ml Is a True Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Inferred relationship Existential restriction modifier
Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) 100 ml Is a True Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Inferred relationship Existential restriction modifier
Diprosalic scalp application (Sigma Pharmaceuticals Plc) 100 ml Is a True Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Inferred relationship Existential restriction modifier
Diprosalic scalp application (Lexon (UK) Ltd) 100 ml Is a True Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Inferred relationship Existential restriction modifier
Diprosalic scalp application (Mawdsley-Brooks & Company Ltd) 100 ml Is a True Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Inferred relationship Existential restriction modifier
Diprosalic scalp application (Necessity Supplies Ltd) 100 ml Is a True Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start